SII Q-VAC

Description

SII Q-VAC is a tetravalent combination vaccine containing Diphtheria toxoid, Tetanus toxoid, killed Bordetella pertussis bacilli and rec Hepatitis B surface antigen. It is indicated for the active immunization of infants, at or above the age of 6 weeks of birth and of children through 6 years of age against Diphtheria, Tetanus, Whooping cough and Hepatitis B. The combined vaccine can be given safely and effectively at the same time as BCG, Measles and Polio vaccines (OPV and IPV), Hib, Yellow Fever vaccines and Vitamin A supplementation.

DTP-HB vaccine does not prevent Hepatitis caused by other agents different from HBV (as virus A, C and E) but it is considered effective in preventing Hepatitis caused by the delta agent.

Immunization guideline:

For active immunization of infants and preschool children, it is recommended that three intramuscular injection of 0.5 ml be administered with an interval of four weeks between doses at 6, 10 and 14 weeks of age. Monovalent birth dose of Hep B should be given. DTP Boosters should not contain HepB component.

For latest IAP updates see revised immunization schedule.

Additional information

manufacturer

Serum Institute of India Ltd.

country-of-manufacture

India

vaccine-type

Diphtheria-Tetanus-Pertussis-Hepatitis B

pharmaceutical-form

Liquid

package-size

1 Dose

route-of-administration

Intramuscular

Contraindications

Hypersensitivity to any component of the vaccine, presence of any evolving neurological condition, Encephalopathy after a previous dose. Immunization should be deferred during the cause of an acute illness, and severe, febrile illness until recovery. However, the presence of minor illnesses such as mild upper respiratory infections with or without low-grade fever are not contraindications to further use. Elective immunization procedures should be deferred during an outbreak of poliomyelitis.